Top 15 Health Care Angel Investors in Belgium in October 2024
A list of 15 angel investors that invest in Health care startups based in Belgium. We rank investors based on the number of investments they made in Health care companies from Belgium. We update this investor list every month.Top 15 Health Care Angel Investors in Belgium in October 2024
Investor | Health Care Belgium investments |
---|---|
Annie Vereecken | 4 |
Pierre Drion | 3 |
Pierre Rigaux | 3 |
Yves Beudin | 1 |
Kenneth Buckfire | 1 |
Herman Verrelst | 1 |
Jean Dessain | 1 |
Konstantin Mehl | 1 |
David Prior | 1 |
Patrick Keereman | 1 |
Eric Janvier | 1 |
Eyal Gura | 1 |
Eduardo Ronzano | 1 |
Manuel Thurner | 1 |
Evren Ucok | 1 |
Annie Vereecken
Show more
Investment focus
- Biotechnology, Medical, Hospital
- Seed, Series A, Funding Round
- Belgium
Portfolio highlights
- Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
- Sensolus — Introducing our smart, industrial-grade tracking solution. With battery life of up to ten years, and no additional infrastructure needed.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Pierre Drion - CEO @ Petercam
Show more
Investment focus
- Biotechnology, Health Care, Life Science
- Series A, Series B, Funding Round
- Belgium
Portfolio highlights
- A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
- Santero Therapeutics — Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.
Pierre Rigaux
Show more
Investment focus
- Sports, Medical Device
- Seed, Pre-Seed, Convertible Note
- Belgium
Portfolio highlights
- MYOCENE — Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance.
Yves Beudin
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Angel
- Belgium
Portfolio highlights
- OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
Kenneth Buckfire is the Chief Executive Officer at Miller Buckfire.
Show more
Investment focus
- Medical, Health Care, Life Science
- Series A
- Belgium
Portfolio highlights
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Herman Verrelst
Show more
Investment focus
- Medical, Hospital, Biotechnology
- Series A
- Belgium
Portfolio highlights
- UgenTec — FastFinder is intelligent software that automates sample workflow, ensures your assays are analyzed consistently and cuts data analysis time in half.
Jean Dessain - Non Executive Director @ OneLIFE
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Angel
- Belgium
Portfolio highlights
- OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
Konstantin Mehl is the President, CEO, and founder of Kaia Health. Konstantin is a serial entrepreneur. His last company foodora, a global food delivery company was sold to delivery hero in 2015 after reaching 500 employees and 5,000 drivers. His current company Kaia has the mission to build the biggest platform for chronic disease management,powered by computer vision. His angel investments include more than 20 companies in the US and Europe. He holds a dual Masters from Columbia University and a Bachelors degree from Technical University Munich.
Show more
Investment focus
- iOS, Banking, Security
- Pre-Seed, Seed
- Germany, Belgium, United States
David Prior is the former chair of the UK's National Health Service.
Show more
Investment focus
- Health Care, Medical, Software
- Seed
- Belgium, United Kingdom
Portfolio highlights
- TORTUS AI — Innovative medical AI which revolutionises the healthcare industry by enhancing clinical operations and patient care. Book a free demo today.
- Awell Health — Ollie is a vast library of over 100 interface blocks with complete Webflow CMS integration. Build beautiful websites in less time than ever.
Patrick Keereman
Show more
Investment focus
- Medical, Hardware, Software
- Seed
- Belgium
Portfolio highlights
- MOLECUBES — MOLECUBES is a Ghent University spin-off started with the support of iMinds. Springing from the MEDISIP research group and the preclinical INFINITY lab, a team of young hardware and software engineers with hands-on experience grouped together to make a difference in their and your daily imaging practice.We build preclinical imaging cubesallowing you to combine SPECT, PET and CT imaging in almost any lab space. Modular systems leave full flexibility at your side while ensuring full mice and full rat imaging. Intuitive wireless acquisition and reconstruction software allow the systems to be used almost anywhere by anyone. Being built by end-users we also understand the importance of good servicing.
Eric Janvier
Show more
Investment focus
- Medical, Health Care
- Series A
- Belgium
Portfolio highlights
- Elysia — Elysia developed solution dedicated to quality control laboratories for the production of Radio Pharmaceuticals.
Eyal Gura is the Board Member of Imagene AI. He previously worked at Zebra Medical Vision Ltd as a Co-Founder, President and Chairman of the Board. Eyal Gura attended Reichman University (IDC Herzliya).
Show more
Investment focus
- Software, Mobile, Artificial Intelligence
- Series A, Seed, Series B
- United States, Israel, Belgium
Portfolio highlights
- Theator — Discover the world's first surgical intelligence platform from theator. Continually perfect your craft with AI & computer vision technology.
- Taranis — Taranis is a leading precision agriculture intelligence platform that uses sophisticated computer vision, data science, and deep learning algorithms to effectively monitor fields. The system enables farmers to make informed decisions by detecting early symptoms of weeds, uneven emergence, nutrient deficiencies, disease or insect infestations, waterdamage, and machinery problems. Overseeing millions of acres of farmland in Argentina, Brazil, Russia, Ukraine, and the United States, Taranis gives farmers the tools to address issues in real-time, increasing yields and cutting costs. Taranis employs over 100 people worldwide and is headquartered in San Francisco with subsidiaries in Israel, Argentina, and Brazil.
- Imagene AI — Imagene AI provides AI-based molecular testing for cancer, leveraging the patient's histological data for personalized therapy.Our mission at Imagene is to assist cancer patients in receiving the optimal treatment medicine can offer by leveraging AI to detect, in real-time, a broad range of cancerous biomarkers and genomic insights from thebiopsy image alone. By doing so, Imagene overcomes economical, logistical, and technological barriers to reach the full potential of precision medicine for cancer patients.Through collaborations with top-tier medical centers and pharmaceutical companies, Imagene is revolutionizing molecular screening for both clinical practice and research.Our success derives from our cutting-edge technology and talented multidisciplinary team of data scientists, biologists, software engineers, and medical experts.
Eduardo Ronzano is the Co-Founder and CEO of Kolet. He previously worked at The Bradery as a Pre-Seed Investor. Eduardo Ronzano attended ESCP Business School.
Show more
Investment focus
- Software, SaaS, E-Commerce
- Seed, Pre-Seed, Angel
- France, United States, United Kingdom
Manuel Thurner is the Co-Founder and Co-CEO at Kaia Health. He attended the Technical University of Munich, Massachusetts Institute of Technology, and Center for Digital Technology and Management, CDTM.
Show more
Investment focus
- iOS, Software, Navigation
- Pre-Seed, Seed
- Germany, Belgium
Portfolio highlights
- OCELL — Building the Operating System of Sustainable Forestry
- AYES — AYES provides the leading AI service to create accessible mobility for blind and visually impaired people.
- Kranus Health — Kranus Health is a global provider for Men‘s Health Prescription Digital Therapeutics (PDTs). Our therapies make millions of men live a better and longer life and enable doctors to treat their patients more efficiently.
Evren Ucok is a co-founder and investor at Peak Games, an interactive social game development platform.
He is also a partner at Earlybird Venture Capital, an investment fund-based in Europe that focuses on emerging companies; Trendyol.com, a fashion e-commerce site; and Oliver Wyman.
Show more
Investment focus
- Medical, Health Care, Life Science
- Series A
- Turkey, Belgium
Portfolio highlights
- idemama — Idemama is an online platform that provides its users with web and graphic design services. It is based in Istanbul, Turkey.
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Investors by industry
Energy
Climate
Health Care
Gaming
Hardware
Artificial intelligence
Impact
Proptech
Marketplace
Community
FinTech
Google
Consumer
Biotech
EdTech
Sustainability
Venture Capital
Beauty
B2B
Photography
Finance
Real Estate
Big Data
Web3
Clean Energy
Social Media
Oil and Gas
Medical
Email
Art
Video Games
Wellness
Music
Food and Beverage
Mobile
Franchise
Social Network
Local
Publishing
Internet
Digital Media
Construction
Manufacturing
eSports
Education
Sports
Enterprise Software
Legal
Payments
Android
Platforms
Mobile Advertising
Biotechnology
Hospitality
Fitness
Travel
Recruiting
Cannabis
Fashion
Wine And Spirits
Medical Device
Crowdfunding
Social
Automotive
Organic Food
CleanTech
Transportation
Mobile Apps
InsurTech
Retail
Enterprise
Financial Services
Infrastructure
LGBT
Life Science
Theatre
Film
Non Profit
Sporting Goods
Renewable Energy
SaaS
Restaurants
Software
Social Impact
Celebrity
Cryptocurrency
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
India
Germany
South Korea
United Kingdom
Australia
Ireland
New Zealand
Canada
United States
Spain
Indonesia
Singapore
South Africa
Africa
Qatar
Europe
LATAM
Middle East
Sri Lanka
Asia
Armenia
Vietnam
China
Japan
Saudi Arabia
Brazil
Oceania
Czech Republic
Ecuador
Morocco
Barbados
Malta
Costa Rica
Mali
Malaysia
Finland
Italy
Belarus
Peru
France
Lithuania
Myanmar
Estonia
Lebanon
Kuwait
Cayman Islands
Hong Kong
Cambodia
Israel
Panama
Denmark
Mexico
Gibraltar
Kazakhstan
Liberia
Jersey
Philippines
Chile
Norway
Mauritius
Kenya
Bermuda
Liechtenstein
Nicaragua
Belize
Georgia
Turkey
Greece
Serbia
Rwanda
Egypt
El Salvador
Venezuela
Hungary
Ukraine
Portugal
Sierra Leone
Zimbabwe
Sweden
Taiwan
Ethiopia
Senegal
Faroe Islands
Algeria
Uruguay
Ghana
Uganda
Tunisia
San Marino
Slovenia
Belgium
Zambia
Uzbekistan
Russian Federation
Seychelles
Croatia
Thailand
Puerto Rico
Tajikistan
Togo
Poland
Tanzania
Dominican Republic
Bulgaria
Nigeria
Azerbaijan
Namibia
Iceland
Bahrain
Iraq
Bahamas
Honduras
United Arab Emirates
Bolivia
Isle of Man
Luxembourg
Albania
Pakistan
Guatemala
Grenada
Jordan
Romania
Argentina
Bangladesh
Latvia
Cyprus
Oman
Austria
Cameroon
Switzerland
Colombia
Marshall Islands
Angel Investors in Belgium by industry
Biotechnology
Marketplace
Food and Beverage
Financial Services
Big Data
Finance
Life Science
Medical
Medical Device
Internet
Social Media
Manufacturing
Mobile
Software
Sports
Enterprise Software
Mobile Advertising
Hospitality
Automotive
FinTech
Enterprise
Biotech
Health Care
Proptech
Climate
SaaS
Community
Gaming
Publishing
Real Estate
Retail
Transportation
Platforms
Artificial intelligence
Payments
Hardware
Media (entertainment)
Construction